Sustained Inhibition of NF-κB Activity Mitigates Retinal Vasculopathy in Diabetes.

Abstract excerpt

This study investigated the effects of long-term NF-κB inhibition in mitigating retinal vasculopathy in a type 1 diabetic mouse model (Akita, Ins2Akita). Akita and wild-type (C57BL/6J) male mice, 24 to 26 weeks old, were treated with or without a selective inhibitor of NF-κB, 4-methyl-N1-(3-phenyl-propyl) benzene-1,2-diamine (JSH-23), for 4 weeks. Treatment was given when the mice were at least 24 weeks old....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Diabetes Mellitus, Experimental
• Share to Electroretinography